𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Drug Profile: Transdermal Rivastigmine Patch in the Treatment of Alzheimer Disease

✍ Scribed by Murat Emre; Roberto Bernabei; Rafael Blesa; Roger Bullock; Luis Cunha; Hugo Daniëls; Edward Dziadulewicz; Hans Förstl; Lutz Frölich; Tomasz Gabryelewicz; Oleg Levin; James Lindesay; Pablo Martínez-Lage; Andreas Monsch; Magda Tsolaki; Teus Van Laar


Book ID
118076690
Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
158 KB
Volume
16
Category
Article
ISSN
1755-5930

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Rivastigmine transdermal patch and capsu
✍ Martin R. Farlow; George T. Grossberg; Xiangyi Meng; Jason Olin; Monique Somogyi 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 373 KB

## Abstract ## Objectives The cholinesterase inhibitor rivastigmine is approved for the symptomatic treatment of mild to moderate Alzheimer's disease (AD). This exploratory, hypothesis‐forming analysis assessed response to rivastigmine according to severity of dementia at baseline. ## Methods Th